XDH and myocardial infarction: Based on meta-analyses carried out in 2018 and 2020, it was shown that XO inhibition has a protective effect in the secondary prevention of myocardial infarction, major adverse cardiovascular events (MACEs), and an endpoint defined as total cardiovascular events, while in the entire study population, these effects were not statistically significant [123,124].